Vakula I N, Vasianina Iu Sh, Gorbunova Z Kh, Nikiforova E Iu, Ponomarenko E I
Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(8):42-4.
A group of children and adolescents with ADHD (25 boys and 9 girls), aged 6-17 years, were treated with strattera in the optimum dose (1,2 mg/day) on an outpatient basis. The assessment of treatment effectiveness showed the marked and moderately pronounced clinical effect in 78,1% patients after 3 months. The psychological study revealed a positive trend in the volume and speed of switching attention in 80% of children and the improvement of sustainability of attention - in 69%. Control EEG revealed the decrease in the <
一组患有注意力缺陷多动障碍（ADHD）的儿童和青少年（25名男孩和9名女孩），年龄在6至17岁之间，在门诊接受了最优剂量（1.2毫克/天）的择思达治疗。治疗效果评估显示，3个月后78.1%的患者有显著和中度明显的临床效果。心理学研究表明，80%的儿童在注意力转换的量和速度方面呈积极趋势，69%的儿童注意力持续性得到改善。对照脑电图显示，70.2%的患者“减速指数”下降。证实了择思达在治疗儿童和青少年ADHD方面的安全性和良好耐受性。
